ChromaDex (CDXC)
(Delayed Data from NSDQ)
$3.44 USD
+0.05 (1.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for ChromaDex Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 27 | 20 | 28 | 17 | 19 |
Receivables | 5 | 8 | 5 | 3 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 15 | 15 | 14 | 12 | 12 |
Other Current Assets | 2 | 3 | 2 | 1 | 1 |
Total Current Assets | 50 | 47 | 49 | 32 | 34 |
Net Property & Equipment | 2 | 3 | 3 | 3 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1 | 1 | 1 | 1 | 1 |
Deposits & Other Assets | 0 | 1 | 1 | 1 | 1 |
Total Assets | 55 | 54 | 58 | 38 | 40 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 10 | 10 | 10 | 9 | 10 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 7 | 6 | 6 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 21 | 18 | 18 | 16 | 15 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3 | 4 | 4 | 4 | 4 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 27 | 25 | 26 | 22 | 20 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 219 | 214 | 201 | 158 | 142 |
Retained Earnings | -190 | -185 | -169 | -142 | -122 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 28 | 29 | 32 | 16 | 20 |
Total Liabilities & Shareholder's Equity | 55 | 54 | 58 | 38 | 40 |
Total Common Equity | 28 | 29 | 32 | 16 | 20 |
Shares Outstanding | 75.10 | 74.40 | 68.20 | 61.70 | 59.50 |
Book Value Per Share | 0.38 | 0.39 | 0.47 | 0.27 | 0.34 |
Fiscal Year End for ChromaDex Corporation falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 27 | 27 | 26 | 23 |
Receivables | NA | 5 | 6 | 6 | 9 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 15 | 13 | 12 | 12 |
Other Current Assets | NA | 2 | 2 | 2 | 2 |
Total Current Assets | NA | 50 | 47 | 46 | 47 |
Net Property & Equipment | NA | 2 | 2 | 3 | 3 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1 | 1 | 1 | 1 |
Deposits & Other Assets | NA | 0 | 0 | 1 | 1 |
Total Assets | NA | 55 | 53 | 53 | 54 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 10 | 9 | 10 | 9 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 9 | 9 | 8 | 9 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 21 | 19 | 19 | 18 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 3 | 4 | 4 | 4 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 27 | 26 | 26 | 26 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 219 | 218 | 217 | 215 |
Retained Earnings | NA | -190 | -191 | -190 | -187 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 28 | 27 | 27 | 28 |
Total Liabilities & Shareholder's Equity | NA | 55 | 53 | 53 | 54 |
Total Common Equity | 0 | 28 | 27 | 27 | 28 |
Shares Outstanding | 75.30 | 75.10 | 75.00 | 74.90 | 74.80 |
Book Value Per Share | 0.00 | 0.38 | 0.36 | 0.36 | 0.37 |